基于2024年欧洲血管外科学会腹主动脉瘤诊疗指南谈髂动脉瘤治疗指征的变化  

Changes in therapeutic indications of iliac artery aneurysms: from European Society for Vascular Surgery (ESVS) 2024 clinical practice guidelines on the management of abdominal aorto-iliac artery aneurysms

作　　者：蔡明豪 司逸 符伟国 Cai Minghao;Si Yi;Fu Weiguo(Deparment of Vascular Surgery,Zhongshan Hospital,Fudan University,Shanghai 200032,China)

机构地区：[1]复旦大学附属中山医院血管外科,上海200032

出　　处：《中华血管外科杂志》2024年第5期291-296,共6页Chinese Journal of Vascular Surgery

基　　金：国家自然科学基金项目(82070497)。

摘　　要：无论是孤立性髂动脉瘤还是腹主动脉瘤合并髂动脉瘤的患者, 成功重建髂动脉是治疗的关键之一。随着腔内技术和器械的发展, 腔内修复髂动脉瘤已逐渐取代开放手术, 成为首选的治疗方式。常见的方法是牺牲髂内动脉血流, 并行髂动脉瘤修复, 但这种方法增加了盆腔器官缺血的并发症发生率。近年来围绕着保留和重建髂内动脉, 在腔内技术和器械的持续进步下, 发展出了多种手术方式和器械。本文结合国际临床研究和历年欧洲血管外科学会腹主动脉瘤诊疗指南, 阐述髂内动脉保留和重建策略在髂动脉瘤治疗指征方面的变化。Successful reconstruction of the iliac artery is one of the keys to the treatment of either the isolated iliac artery aneurysm or the abdominal aortic aneurysm combined with iliac artery aneurysm.With the development of endovascular techniques and devices,endovascular repair of the iliac artery aneurysm has gradually replaced open surgery and become the first choice for treatment.A common approach is to repair the iliac artery aneurysm with the sacrifice of the internal iliac artery,which increases the risk of ischemia in pelvic organs as a complication.Therefore,in recent years,endovascular techniques and devices have continued to advance for the reservation and reconstruction of the internal iliac artery,with the development of various surgical approaches and devices.This article aims to describe the changes in internal iliac artery reservation and reconstruction strategies in terms of therapeutic indications of iliac artery aneurysms,combining international clinical studies and ESVS clinical practice guidelines on the management of abdominal aorto-iliac artery aneurysms published over the years.

关 键 词：髂动脉瘤 腔内治疗 髂内动脉重建 治疗指征 指南 

分 类 号：R65[医药卫生—外科学]